STOCKHOLM, Aug. 28, 2023 /PRNewswire/ — The prospectus regarding the rights issue of ordinary shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) (‘Sobi’) amounting to approximately SEK 6,024 million, which was resolved by the Board of Directors of Sobi on 22 August 2023…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.